SEC 13F Intelligence

Stance Capital LLC / BMY

Stance Capital LLC’s Bristol-Myers Squibb Co Position

Does Stance Capital LLC own Bristol-Myers Squibb Co (BMY)? Yes — 84.2K shares worth $5M (+2.48% of its 13F portfolio) as of Q1 2026, up from 35.0K shares the prior filed quarter.

Position Value
$5M
Q1 2026
Shares
84.2K
% of Portfolio
+2.48%
Quarters Held
4
currently held

Position History BMY

Reported value by quarter
Q1 ’25: $3MQ1 ’25Q2 ’25: $2MQ2 ’25Q3 ’25: $2MQ3 ’25Q1 ’26: $5MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202684.2K$5M+2.48%
Q3 202535.0K$2M+0.58%
Q2 202533.2K$2M+0.58%
Q1 202542.4K$3M+1.91%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Stance Capital LLC’s full portfolio or all institutional holders of BMY.